BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 37341833)

  • 1. Microglial Metabolic Reprogramming: Emerging Insights and Therapeutic Strategies in Neurodegenerative Diseases.
    Miao J; Chen L; Pan X; Li L; Zhao B; Lan J
    Cell Mol Neurobiol; 2023 Oct; 43(7):3191-3210. PubMed ID: 37341833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming and polarization of microglia in Parkinson's disease: Role of inflammasome and iron.
    Yu H; Chang Q; Sun T; He X; Wen L; An J; Feng J; Zhao Y
    Ageing Res Rev; 2023 Sep; 90():102032. PubMed ID: 37572760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycometabolic Reprogramming of Microglia in Neurodegenerative Diseases: Insights from Neuroinflammation.
    Huang Q; Wang Y; Chen S; Liang F
    Aging Dis; 2024 May; 15(3):1155-1175. PubMed ID: 37611905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of microglial metabolic reprogramming in Parkinson's disease.
    Huang ZP; Liu SF; Zhuang JL; Li LY; Li MM; Huang YL; Chen YH; Chen XR; Lin S; Ye LC; Chen CN
    Biochem Pharmacol; 2023 Jul; 213():115619. PubMed ID: 37211170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics.
    Lepiarz-Raba I; Gbadamosi I; Florea R; Paolicelli RC; Jawaid A
    Transl Neurodegener; 2023 Oct; 12(1):48. PubMed ID: 37908010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of microglia immunometabolism in neurodegeneration: Focus on molecular determinants and metabolic intermediates of metabolic reprogramming.
    Wang Q; Lu M; Zhu X; Gu X; Zhang T; Xia C; Yang L; Xu Y; Zhou M
    Biomed Pharmacother; 2022 Sep; 153():113412. PubMed ID: 36076537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammation: An overview of neurodegenerative and metabolic diseases and of biotechnological studies.
    de Araújo Boleti AP; de Oliveira Flores TM; Moreno SE; Anjos LD; Mortari MR; Migliolo L
    Neurochem Int; 2020 Jun; 136():104714. PubMed ID: 32165170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early glycolytic reprogramming controls microglial inflammatory activation.
    Cheng J; Zhang R; Xu Z; Ke Y; Sun R; Yang H; Zhang X; Zhen X; Zheng LT
    J Neuroinflammation; 2021 Jun; 18(1):129. PubMed ID: 34107997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammation, microglial activation, and glucose metabolism in neurodegenerative diseases.
    Edison P
    Int Rev Neurobiol; 2020; 154():325-344. PubMed ID: 32739010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson's disease.
    Lu J; Wang C; Cheng X; Wang R; Yan X; He P; Chen H; Yu Z
    J Neuroinflammation; 2022 May; 19(1):113. PubMed ID: 35599331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglial phagocytosis of neurons in neurodegeneration, and its regulation.
    Butler CA; Popescu AS; Kitchener EJA; Allendorf DH; Puigdellívol M; Brown GC
    J Neurochem; 2021 Aug; 158(3):621-639. PubMed ID: 33608912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Reprograming of Microglia in the Regulation of the Innate Inflammatory Response.
    Lauro C; Limatola C
    Front Immunol; 2020; 11():493. PubMed ID: 32265936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in microglia: deciphering their role in neurodegenerative diseases.
    Jadhav SP
    Front Cell Neurosci; 2024; 18():1391537. PubMed ID: 38812793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglial Turnover in Ageing-Related Neurodegeneration: Therapeutic Avenue to Intervene in Disease Progression.
    Azam S; Haque ME; Kim IS; Choi DK
    Cells; 2021 Jan; 10(1):. PubMed ID: 33466587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglial Potassium Channels: From Homeostasis to Neurodegeneration.
    Cocozza G; Garofalo S; Capitani R; D'Alessandro G; Limatola C
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets.
    Gao C; Jiang J; Tan Y; Chen S
    Signal Transduct Target Ther; 2023 Sep; 8(1):359. PubMed ID: 37735487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia-mediated neuroinflammation in neurodegenerative diseases.
    Subhramanyam CS; Wang C; Hu Q; Dheen ST
    Semin Cell Dev Biol; 2019 Oct; 94():112-120. PubMed ID: 31077796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ion channels on microglia: therapeutic targets for neuroprotection.
    Skaper SD
    CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):44-56. PubMed ID: 21143139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial Immunometabolism in Alzheimer's Disease.
    Shippy DC; Ulland TK
    Front Cell Neurosci; 2020; 14():563446. PubMed ID: 33192310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.